Loading...

Seagen Inc.

SGEN•NASDAQ
Healthcare
Biotechnology
$228.74
$-0.16(-0.07%)

Seagen Inc. (SGEN) Stock Overview

Explore Seagen Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.5/100

Key Financials

Market Cap43.2B
P/E Ratio-69.22
EPS (TTM)$-4.00
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$335.06

SGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Seagen Inc. (SGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $335.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -69.22 and a market capitalization of 43.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;